Lakhi Sakhrani – FDA 483, Feb 5, 2016
An FDA inspection of Lakhi Sakhrani, a clinical investigator in San Gabriel, CA, revealed significant deficiencies in conducting clinical investigations and maintaining accurate records. Observations included failure to follow the investigational plan, such as not reporting required lab results due to samples exceeding stability and not suspending subject dosing as instructed. Additionally, widespread inaccuracies and omissions were found in case histories, concomitant medication reporting, adverse event reporting, and study drug accountability within the eCRF system.
ID · 35f01ede-07c8-4b96-9e0c-778b5018df0c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.